CGMP Adenovirus Production
Adenovirus based gene therapy approaches, including oncolytic adenoviruses, continue to be of high interest to many research groups. At Vigene, we are passionate about our mission to help support scientists advance their biomedical research and, ultimately, to make gene therapy affordable and accessible to those in need. As a leader in CGMP adenovirus vector production, we have the experience and dedication to quality that you need to scale up your adenovirus gene therapy project into a patient-ready product. We know that there is no single production strategy that works best for all CGMP adenovirus projects, so we offer the flexibility of multiple adenovirus vector production methods and the expert knowledge to help you decide which process will best meet your individual needs.
Interested in CGMP adenovirus production? Contact us today for a free consultation >